Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients

Background: Antituberculosis (anti-TB) drugs could cause serious effect such as hepatotoxicity signed by the increase of Alanine Aminotransferase (ALT) level. Anti-TB drugs are still needed by TB patients who have hepatotoxicity, although  clinicians who manage this condition have not recognize whet...

Full description

Bibliographic Details
Main Authors: Vera Dianwari, Vycke Yunivita Kusumah Dewi, Nia Kania
Format: Article
Language:English
Published: Universitas Padjadjaran 2017-12-01
Series:Althea Medical Journal
Subjects:
Online Access:http://journal.fk.unpad.ac.id/index.php/amj/article/view/1259
id doaj-00e49e151a0f4e6a85f826400a657444
record_format Article
spelling doaj-00e49e151a0f4e6a85f826400a6574442020-11-24T21:32:32ZengUniversitas PadjadjaranAlthea Medical Journal2337-43302017-12-014450651110.15850/amj.v4n4.1259936Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis PatientsVera Dianwari0Vycke Yunivita Kusumah Dewi1Nia Kania2Faculty of Medicine, Universitas PadjadjaranDepartment of Pharmacology and Therapy Faculty of Medicine Universitas PadjadjaranDepartement of Anatomy and Cell Biology, Faculty of Medicine, Universitas Padjadjaran, BandungBackground: Antituberculosis (anti-TB) drugs could cause serious effect such as hepatotoxicity signed by the increase of Alanine Aminotransferase (ALT) level. Anti-TB drugs are still needed by TB patients who have hepatotoxicity, although  clinicians who manage this condition have not recognize whether the advantage of anti-TB drugs is higher than its adverse effect, and there is no data describing about that issue. This study was conducted to discover the liver damage based on the ALT changes before and 12 days after initial anti-TB treatment. Methods: This was a cross-sectional study with total sampling of medical records of pulmonary tuberculosis inpatients from 1st January 2013–31th December 2014 at the Department of Internal Medicine of Dr. Hasan Sadikin.General Hospital. From 141 data, only 14 medical records were eligible to be included in this study. The data used were ALT level before and after therapy. These data were analyzed using Wilcoxon test and considered as significant if p<0.05. Results: The median age of the subject study was 48(18-65) years. Among 14 patients, 8 were female and 6 were male. Five out of fourteen patients developed hepatotoxicity. Four out of five developed grade 1 hepatotoxicity and one out of five developed hepatotoxicity grade 4. The analysis of the data showed the differences of ALT level before anti-TB therapy (22(4-447)) and 12 days after initial therapy (18.5(4-1206)) was not significant (p=0.660). Conclusions: There is no liver damage based on ALT changes after anti-TB treatment so the treatment can be continued.http://journal.fk.unpad.ac.id/index.php/amj/article/view/1259Alanine aminotransferase, antituberculosis drugshepatotoxicitytuberculosis
collection DOAJ
language English
format Article
sources DOAJ
author Vera Dianwari
Vycke Yunivita Kusumah Dewi
Nia Kania
spellingShingle Vera Dianwari
Vycke Yunivita Kusumah Dewi
Nia Kania
Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients
Althea Medical Journal
Alanine aminotransferase, antituberculosis drugs
hepatotoxicity
tuberculosis
author_facet Vera Dianwari
Vycke Yunivita Kusumah Dewi
Nia Kania
author_sort Vera Dianwari
title Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients
title_short Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients
title_full Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients
title_fullStr Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients
title_full_unstemmed Effect of Anti-tuberculosis Drugs on Liver Damage Based on Alanine Aminotransferase Level in Pulmonary Tuberculosis Patients
title_sort effect of anti-tuberculosis drugs on liver damage based on alanine aminotransferase level in pulmonary tuberculosis patients
publisher Universitas Padjadjaran
series Althea Medical Journal
issn 2337-4330
publishDate 2017-12-01
description Background: Antituberculosis (anti-TB) drugs could cause serious effect such as hepatotoxicity signed by the increase of Alanine Aminotransferase (ALT) level. Anti-TB drugs are still needed by TB patients who have hepatotoxicity, although  clinicians who manage this condition have not recognize whether the advantage of anti-TB drugs is higher than its adverse effect, and there is no data describing about that issue. This study was conducted to discover the liver damage based on the ALT changes before and 12 days after initial anti-TB treatment. Methods: This was a cross-sectional study with total sampling of medical records of pulmonary tuberculosis inpatients from 1st January 2013–31th December 2014 at the Department of Internal Medicine of Dr. Hasan Sadikin.General Hospital. From 141 data, only 14 medical records were eligible to be included in this study. The data used were ALT level before and after therapy. These data were analyzed using Wilcoxon test and considered as significant if p<0.05. Results: The median age of the subject study was 48(18-65) years. Among 14 patients, 8 were female and 6 were male. Five out of fourteen patients developed hepatotoxicity. Four out of five developed grade 1 hepatotoxicity and one out of five developed hepatotoxicity grade 4. The analysis of the data showed the differences of ALT level before anti-TB therapy (22(4-447)) and 12 days after initial therapy (18.5(4-1206)) was not significant (p=0.660). Conclusions: There is no liver damage based on ALT changes after anti-TB treatment so the treatment can be continued.
topic Alanine aminotransferase, antituberculosis drugs
hepatotoxicity
tuberculosis
url http://journal.fk.unpad.ac.id/index.php/amj/article/view/1259
work_keys_str_mv AT veradianwari effectofantituberculosisdrugsonliverdamagebasedonalanineaminotransferaselevelinpulmonarytuberculosispatients
AT vyckeyunivitakusumahdewi effectofantituberculosisdrugsonliverdamagebasedonalanineaminotransferaselevelinpulmonarytuberculosispatients
AT niakania effectofantituberculosisdrugsonliverdamagebasedonalanineaminotransferaselevelinpulmonarytuberculosispatients
_version_ 1725957157820563456